Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
BMC Infectious Diseases|March 5, 2014
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusHilary A Robbins, Yan Li, Carolina Porras, et al.
The Lancet. Global Health|February 16, 2024
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trialsKathy Baisley, Troy J Kemp, Nelly R Mugo, et al.
Microbiology Spectrum|January 12, 2022
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology AssaysLigia A Pinto, Ribhi M Shawar, Brendan O'Leary, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Carcinogenesis|April 25, 2015
Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehydeWei Jie Seow, Luoping Zhang, Roel Vermeulen, et al.
Carcinogenesis|October 3, 2017
Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in ChinaBryan A Bassig, Yufei Dai, Roel Vermeulen, et al.
International Journal of Cancer|June 23, 2015
Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohortsBryan A Bassig, Xiao-Ou Shu, Woon-Puay Koh, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
JAMA Oncology|February 28, 2020
Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical TrialPamela Stratton, Minoo Battiwalla, Xin Tian, et al.
Pageof 12